The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year.
This report aims to provide a comprehensive presentation of the global market for Diabetic Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Therapeutic. This report contains market size and forecasts of Diabetic Therapeutic in global, including the following market information:
Global Diabetic Therapeutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diabetic Therapeutic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The report identifies the increasing focus on the self-management of diabetes to be one of the major factors that will have a positive impact on the growth of this market in the coming years. With the recent years witnessing an increase in number of people diagnosed with type 1 diabetes, there has been considerable increase in the adoption of insulin delivery systems. Focusing on skipping the need to schedule appointments and reduce expenses for clinical visits, increases the adoption of insulin delivery systems, where individuals use insulin injections at home under the guidance of a physician. This led to the introduction of insulin pens, pumps, and jet injectors, which, in turn, will drive the growth of the diabetic therapeutics market.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Therapeutic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetic Therapeutic Market Segment Percentages, by Type, 2022 (%)
- Sulphonylureas
- Biguanides
- Meglitinides
- Thiazolidinediones
- Alpha-glucosidase Inhibitors
- DPP-4 Inhibitors
- SGLT-2 Inhibitors
Global Diabetic Therapeutic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetic Therapeutic Market Segment Percentages, by Application, 2022 (%)
- Diagnostic/Clinics
- ICUs
- Home Healthcare
Global Diabetic Therapeutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetic Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Therapeutic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetic Therapeutic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi
- Novo Nordisk
- MSD
- Astrazeneca
- Takeda
- Novartis
- AbbVie
- Eli Lilly
- North China Pharmaceutical Group Corporation
- Huadong Medicine
- Dongbao Pharmaceutical
- Hisun Pharmacy
- KELUN
- Ginwa
- Tianan Pharmaceutical
- Jumpcan Pharmacy
- Guangzhou Baiyun Mountain
- SHIJIAZHUANG YILING PHARMACEUTICAL
- Wanbang Biopharmaceuticals
- Gan & Lee
- Taloph
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetic Therapeutic, market overview.
Chapter 2: Global Diabetic Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Diabetic Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetic Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Diabetic Therapeutic Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Diabetic Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetic Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetic Therapeutic Overall Market Size
2.1 Global Diabetic Therapeutic Market Size: 2022 VS 2029
2.2 Global Diabetic Therapeutic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetic Therapeutic Players in Global Market
3.2 Top Global Diabetic Therapeutic Companies Ranked by Revenue
3.3 Global Diabetic Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetic Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Diabetic Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetic Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetic Therapeutic Market Size Markets, 2022 & 2029
4.1.2 Sulphonylureas
4.1.3 Biguanides
4.1.4 Meglitinides
4.1.5 Thiazolidinediones
4.1.6 Alpha-glucosidase Inhibitors
4.1.7 DPP-4 Inhibitors
4.1.8 SGLT-2 Inhibitors
4.2 By Type - Global Diabetic Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Diabetic Therapeutic Revenue, 2018-2023
4.2.2 By Type - Global Diabetic Therapeutic Revenue, 2024-2029
4.2.3 By Type - Global Diabetic Therapeutic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetic Therapeutic Market Size, 2022 & 2029
5.1.2 Diagnostic/Clinics
5.1.3 ICUs
5.1.4 Home Healthcare
5.2 By Application - Global Diabetic Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Diabetic Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global Diabetic Therapeutic Revenue, 2024-2029
5.2.3 By Application - Global Diabetic Therapeutic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Diabetic Therapeutic Market Size, 2022 & 2029
6.2 By Region - Global Diabetic Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Diabetic Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global Diabetic Therapeutic Revenue, 2024-2029
6.2.3 By Region - Global Diabetic Therapeutic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Diabetic Therapeutic Revenue, 2018-2029
6.3.2 US Diabetic Therapeutic Market Size, 2018-2029
6.3.3 Canada Diabetic Therapeutic Market Size, 2018-2029
6.3.4 Mexico Diabetic Therapeutic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Diabetic Therapeutic Revenue, 2018-2029
6.4.2 Germany Diabetic Therapeutic Market Size, 2018-2029
6.4.3 France Diabetic Therapeutic Market Size, 2018-2029
6.4.4 U.K. Diabetic Therapeutic Market Size, 2018-2029
6.4.5 Italy Diabetic Therapeutic Market Size, 2018-2029
6.4.6 Russia Diabetic Therapeutic Market Size, 2018-2029
6.4.7 Nordic Countries Diabetic Therapeutic Market Size, 2018-2029
6.4.8 Benelux Diabetic Therapeutic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Diabetic Therapeutic Revenue, 2018-2029
6.5.2 China Diabetic Therapeutic Market Size, 2018-2029
6.5.3 Japan Diabetic Therapeutic Market Size, 2018-2029
6.5.4 South Korea Diabetic Therapeutic Market Size, 2018-2029
6.5.5 Southeast Asia Diabetic Therapeutic Market Size, 2018-2029
6.5.6 India Diabetic Therapeutic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Diabetic Therapeutic Revenue, 2018-2029
6.6.2 Brazil Diabetic Therapeutic Market Size, 2018-2029
6.6.3 Argentina Diabetic Therapeutic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetic Therapeutic Revenue, 2018-2029
6.7.2 Turkey Diabetic Therapeutic Market Size, 2018-2029
6.7.3 Israel Diabetic Therapeutic Market Size, 2018-2029
6.7.4 Saudi Arabia Diabetic Therapeutic Market Size, 2018-2029
6.7.5 UAE Diabetic Therapeutic Market Size, 2018-2029
7 Diabetic Therapeutic Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Diabetic Therapeutic Major Product Offerings
7.1.4 Sanofi Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Novo Nordisk
7.2.1 Novo Nordisk Company Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Diabetic Therapeutic Major Product Offerings
7.2.4 Novo Nordisk Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Novo Nordisk Key News & Latest Developments
7.3 MSD
7.3.1 MSD Company Summary
7.3.2 MSD Business Overview
7.3.3 MSD Diabetic Therapeutic Major Product Offerings
7.3.4 MSD Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.3.5 MSD Key News & Latest Developments
7.4 Astrazeneca
7.4.1 Astrazeneca Company Summary
7.4.2 Astrazeneca Business Overview
7.4.3 Astrazeneca Diabetic Therapeutic Major Product Offerings
7.4.4 Astrazeneca Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.4.5 Astrazeneca Key News & Latest Developments
7.5 Takeda
7.5.1 Takeda Company Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Diabetic Therapeutic Major Product Offerings
7.5.4 Takeda Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.5.5 Takeda Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Diabetic Therapeutic Major Product Offerings
7.6.4 Novartis Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Diabetic Therapeutic Major Product Offerings
7.7.4 AbbVie Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Diabetic Therapeutic Major Product Offerings
7.8.4 Eli Lilly Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 North China Pharmaceutical Group Corporation
7.9.1 North China Pharmaceutical Group Corporation Company Summary
7.9.2 North China Pharmaceutical Group Corporation Business Overview
7.9.3 North China Pharmaceutical Group Corporation Diabetic Therapeutic Major Product Offerings
7.9.4 North China Pharmaceutical Group Corporation Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.9.5 North China Pharmaceutical Group Corporation Key News & Latest Developments
7.10 Huadong Medicine
7.10.1 Huadong Medicine Company Summary
7.10.2 Huadong Medicine Business Overview
7.10.3 Huadong Medicine Diabetic Therapeutic Major Product Offerings
7.10.4 Huadong Medicine Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.10.5 Huadong Medicine Key News & Latest Developments
7.11 Dongbao Pharmaceutical
7.11.1 Dongbao Pharmaceutical Company Summary
7.11.2 Dongbao Pharmaceutical Business Overview
7.11.3 Dongbao Pharmaceutical Diabetic Therapeutic Major Product Offerings
7.11.4 Dongbao Pharmaceutical Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.11.5 Dongbao Pharmaceutical Key News & Latest Developments
7.12 Hisun Pharmacy
7.12.1 Hisun Pharmacy Company Summary
7.12.2 Hisun Pharmacy Business Overview
7.12.3 Hisun Pharmacy Diabetic Therapeutic Major Product Offerings
7.12.4 Hisun Pharmacy Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.12.5 Hisun Pharmacy Key News & Latest Developments
7.13 KELUN
7.13.1 KELUN Company Summary
7.13.2 KELUN Business Overview
7.13.3 KELUN Diabetic Therapeutic Major Product Offerings
7.13.4 KELUN Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.13.5 KELUN Key News & Latest Developments
7.14 Ginwa
7.14.1 Ginwa Company Summary
7.14.2 Ginwa Business Overview
7.14.3 Ginwa Diabetic Therapeutic Major Product Offerings
7.14.4 Ginwa Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.14.5 Ginwa Key News & Latest Developments
7.15 Tianan Pharmaceutical
7.15.1 Tianan Pharmaceutical Company Summary
7.15.2 Tianan Pharmaceutical Business Overview
7.15.3 Tianan Pharmaceutical Diabetic Therapeutic Major Product Offerings
7.15.4 Tianan Pharmaceutical Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.15.5 Tianan Pharmaceutical Key News & Latest Developments
7.16 Jumpcan Pharmacy
7.16.1 Jumpcan Pharmacy Company Summary
7.16.2 Jumpcan Pharmacy Business Overview
7.16.3 Jumpcan Pharmacy Diabetic Therapeutic Major Product Offerings
7.16.4 Jumpcan Pharmacy Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.16.5 Jumpcan Pharmacy Key News & Latest Developments
7.17 Guangzhou Baiyun Mountain
7.17.1 Guangzhou Baiyun Mountain Company Summary
7.17.2 Guangzhou Baiyun Mountain Business Overview
7.17.3 Guangzhou Baiyun Mountain Diabetic Therapeutic Major Product Offerings
7.17.4 Guangzhou Baiyun Mountain Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.17.5 Guangzhou Baiyun Mountain Key News & Latest Developments
7.18 SHIJIAZHUANG YILING PHARMACEUTICAL
7.18.1 SHIJIAZHUANG YILING PHARMACEUTICAL Company Summary
7.18.2 SHIJIAZHUANG YILING PHARMACEUTICAL Business Overview
7.18.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetic Therapeutic Major Product Offerings
7.18.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.18.5 SHIJIAZHUANG YILING PHARMACEUTICAL Key News & Latest Developments
7.19 Wanbang Biopharmaceuticals
7.19.1 Wanbang Biopharmaceuticals Company Summary
7.19.2 Wanbang Biopharmaceuticals Business Overview
7.19.3 Wanbang Biopharmaceuticals Diabetic Therapeutic Major Product Offerings
7.19.4 Wanbang Biopharmaceuticals Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.19.5 Wanbang Biopharmaceuticals Key News & Latest Developments
7.20 Gan & Lee
7.20.1 Gan & Lee Company Summary
7.20.2 Gan & Lee Business Overview
7.20.3 Gan & Lee Diabetic Therapeutic Major Product Offerings
7.20.4 Gan & Lee Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.20.5 Gan & Lee Key News & Latest Developments
7.21 Taloph
7.21.1 Taloph Company Summary
7.21.2 Taloph Business Overview
7.21.3 Taloph Diabetic Therapeutic Major Product Offerings
7.21.4 Taloph Diabetic Therapeutic Revenue in Global Market (2018-2023)
7.21.5 Taloph Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Diabetic Therapeutic Market Opportunities & Trends in Global Market
Table 2. Diabetic Therapeutic Market Drivers in Global Market
Table 3. Diabetic Therapeutic Market Restraints in Global Market
Table 4. Key Players of Diabetic Therapeutic in Global Market
Table 5. Top Diabetic Therapeutic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetic Therapeutic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetic Therapeutic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetic Therapeutic Product Type
Table 9. List of Global Tier 1 Diabetic Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Diabetic Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Diabetic Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetic Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application - Global Diabetic Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Diabetic Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetic Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region - Global Diabetic Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Diabetic Therapeutic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetic Therapeutic Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Diabetic Therapeutic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetic Therapeutic Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Diabetic Therapeutic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetic Therapeutic Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Diabetic Therapeutic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetic Therapeutic Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Diabetic Therapeutic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetic Therapeutic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Diabetic Therapeutic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetic Therapeutic Revenue, (US$, Mn), 2024-2029
Table 30. Sanofi Company Summary
Table 31. Sanofi Diabetic Therapeutic Product Offerings
Table 32. Sanofi Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Novo Nordisk Company Summary
Table 35. Novo Nordisk Diabetic Therapeutic Product Offerings
Table 36. Novo Nordisk Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 37. Novo Nordisk Key News & Latest Developments
Table 38. MSD Company Summary
Table 39. MSD Diabetic Therapeutic Product Offerings
Table 40. MSD Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 41. MSD Key News & Latest Developments
Table 42. Astrazeneca Company Summary
Table 43. Astrazeneca Diabetic Therapeutic Product Offerings
Table 44. Astrazeneca Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 45. Astrazeneca Key News & Latest Developments
Table 46. Takeda Company Summary
Table 47. Takeda Diabetic Therapeutic Product Offerings
Table 48. Takeda Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 49. Takeda Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Diabetic Therapeutic Product Offerings
Table 52. Novartis Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Diabetic Therapeutic Product Offerings
Table 56. AbbVie Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Diabetic Therapeutic Product Offerings
Table 60. Eli Lilly Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. North China Pharmaceutical Group Corporation Company Summary
Table 63. North China Pharmaceutical Group Corporation Diabetic Therapeutic Product Offerings
Table 64. North China Pharmaceutical Group Corporation Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 65. North China Pharmaceutical Group Corporation Key News & Latest Developments
Table 66. Huadong Medicine Company Summary
Table 67. Huadong Medicine Diabetic Therapeutic Product Offerings
Table 68. Huadong Medicine Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 69. Huadong Medicine Key News & Latest Developments
Table 70. Dongbao Pharmaceutical Company Summary
Table 71. Dongbao Pharmaceutical Diabetic Therapeutic Product Offerings
Table 72. Dongbao Pharmaceutical Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 73. Dongbao Pharmaceutical Key News & Latest Developments
Table 74. Hisun Pharmacy Company Summary
Table 75. Hisun Pharmacy Diabetic Therapeutic Product Offerings
Table 76. Hisun Pharmacy Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 77. Hisun Pharmacy Key News & Latest Developments
Table 78. KELUN Company Summary
Table 79. KELUN Diabetic Therapeutic Product Offerings
Table 80. KELUN Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 81. KELUN Key News & Latest Developments
Table 82. Ginwa Company Summary
Table 83. Ginwa Diabetic Therapeutic Product Offerings
Table 84. Ginwa Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 85. Ginwa Key News & Latest Developments
Table 86. Tianan Pharmaceutical Company Summary
Table 87. Tianan Pharmaceutical Diabetic Therapeutic Product Offerings
Table 88. Tianan Pharmaceutical Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 89. Tianan Pharmaceutical Key News & Latest Developments
Table 90. Jumpcan Pharmacy Company Summary
Table 91. Jumpcan Pharmacy Diabetic Therapeutic Product Offerings
Table 92. Jumpcan Pharmacy Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 93. Jumpcan Pharmacy Key News & Latest Developments
Table 94. Guangzhou Baiyun Mountain Company Summary
Table 95. Guangzhou Baiyun Mountain Diabetic Therapeutic Product Offerings
Table 96. Guangzhou Baiyun Mountain Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 97. Guangzhou Baiyun Mountain Key News & Latest Developments
Table 98. SHIJIAZHUANG YILING PHARMACEUTICAL Company Summary
Table 99. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetic Therapeutic Product Offerings
Table 100. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 101. SHIJIAZHUANG YILING PHARMACEUTICAL Key News & Latest Developments
Table 102. Wanbang Biopharmaceuticals Company Summary
Table 103. Wanbang Biopharmaceuticals Diabetic Therapeutic Product Offerings
Table 104. Wanbang Biopharmaceuticals Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 105. Wanbang Biopharmaceuticals Key News & Latest Developments
Table 106. Gan & Lee Company Summary
Table 107. Gan & Lee Diabetic Therapeutic Product Offerings
Table 108. Gan & Lee Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 109. Gan & Lee Key News & Latest Developments
Table 110. Taloph Company Summary
Table 111. Taloph Diabetic Therapeutic Product Offerings
Table 112. Taloph Diabetic Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 113. Taloph Key News & Latest Developments
List of Figures
Figure 1. Diabetic Therapeutic Segment by Type in 2022
Figure 2. Diabetic Therapeutic Segment by Application in 2022
Figure 3. Global Diabetic Therapeutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetic Therapeutic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Diabetic Therapeutic Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Therapeutic Revenue in 2022
Figure 8. By Type - Global Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 9. By Application - Global Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 10. By Type - Global Diabetic Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 12. By Application - Global Diabetic Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 14. By Region - Global Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 15. By Country - North America Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 16. US Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 20. Germany Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 21. France Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 28. China Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 32. India Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 34. Brazil Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Diabetic Therapeutic Revenue Market Share, 2018-2029
Figure 37. Turkey Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Diabetic Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 41. Sanofi Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novo Nordisk Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. MSD Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astrazeneca Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Takeda Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AbbVie Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eli Lilly Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. North China Pharmaceutical Group Corporation Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Huadong Medicine Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Dongbao Pharmaceutical Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Hisun Pharmacy Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. KELUN Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Ginwa Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Tianan Pharmaceutical Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Jumpcan Pharmacy Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Guangzhou Baiyun Mountain Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Wanbang Biopharmaceuticals Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Gan & Lee Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Taloph Diabetic Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
